rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-5-19
|
pubmed:abstractText |
Surgery is considered the mainstay of therapy for clinically resectable esophageal cancer, even though neoadjuvant treatments are frequently added. The aim of this study was to analyse our experience on neoadjuvant treatment of squamous cell carcinoma of the thoracic esophagus with special reference to long-term
|
pubmed:language |
ita
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0026-4733
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15902048-Adult,
pubmed-meshheading:15902048-Aged,
pubmed-meshheading:15902048-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15902048-Carcinoma, Squamous Cell,
pubmed-meshheading:15902048-Chemotherapy, Adjuvant,
pubmed-meshheading:15902048-Cisplatin,
pubmed-meshheading:15902048-Esophageal Neoplasms,
pubmed-meshheading:15902048-Female,
pubmed-meshheading:15902048-Fluorouracil,
pubmed-meshheading:15902048-Humans,
pubmed-meshheading:15902048-Italy,
pubmed-meshheading:15902048-Male,
pubmed-meshheading:15902048-Middle Aged,
pubmed-meshheading:15902048-Neoadjuvant Therapy,
pubmed-meshheading:15902048-Radiotherapy, Adjuvant,
pubmed-meshheading:15902048-Retrospective Studies,
pubmed-meshheading:15902048-Statistics, Nonparametric,
pubmed-meshheading:15902048-Survival Rate,
pubmed-meshheading:15902048-Time Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
[Long-term results of neoadjuvant radiochemotherapy in squamous carcinoma of the thoracic esophagus].
|
pubmed:affiliation |
Prima Divisione Clinicizzata di Chirurgia Generale, Università di Verona, Piazzale Stefani 1, 37126 Verona, Italy.
|
pubmed:publicationType |
Journal Article,
English Abstract
|